Sequencing of CLL Patients Enables Stratification and IDs Potential Drug Targets

The researchers sequenced four CLL patients, identifying recurrent mutations in four different genes, including a potential target for drugs currently in development for other cancers. The patients also had two distinct mutational profiles, corresponding with clinical outcomes.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.